$1.55
0.00% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
US0547544033
Symbol
AYTU

Aytu BioScience Inc Target price 2024 - Analyst rating & recommendation

Aytu BioScience Inc Classifications & Recommendation:

Buy
100%

Aytu BioScience Inc Price Target

Target Price $8.00
Price $1.55
Potential
Number of Estimates 1
1 Analyst has issued a Aytu BioScience Inc price target 2025. The average Aytu BioScience Inc target price is $8.00. This is higher than the current stock price.
A rating was issued by 1 analysts: 1 Analysts recommend Aytu BioScience Inc to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Aytu BioScience Inc stock has an average upside potential 2025 of . Most analysts recommend the Aytu BioScience Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Jun '24 2025
Estimates
Revenue Million $ 81.00 70.35
24.58% 13.15%
EBITDA Margin 6.64% 21.37%
303.23% 221.74%
Net Margin -21.71% 5.25%
25.79% 124.18%

1 Analyst has issued a sales forecast Aytu BioScience Inc 2025 . The average Aytu BioScience Inc sales estimate is

$70.3m
Unlock
. This is
6.80% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$70.3m 6.80%
Unlock
, the lowest is
$70.3m 6.80%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $81.0m 24.58%
2025
$70.3m 13.15%
Unlock
2026
$69.6m 1.05%
Unlock
2027
$69.3m 0.40%
Unlock

1 Analyst has issued an EBITDA forecast Aytu BioScience Inc 2025 . The average Aytu BioScience Inc EBITDA estimate is

$15.0m
Unlock
. This is
143.63% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$15.0m 143.63%
Unlock
, the lowest is
$15.0m 143.63%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $5.4m 253.28%
2025
$15.0m 179.41%
Unlock
2026
$16.7m 11.31%
Unlock
2027
$22.4m 33.60%
Unlock

EBITDA Margin

2024 6.64% 303.23%
2025
21.37% 221.74%
Unlock
2026
24.04% 12.49%
Unlock
2027
32.24% 34.11%
Unlock

1 Analyst has issued a net profit forecast Aytu BioScience Inc 2025 . The average Aytu BioScience Inc net profit estimate is

$3.7m
Unlock
. This is
149.18% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$3.7m 149.18%
Unlock
, the lowest is
$3.7m 149.18%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-17.6m 44.03%
2025
$3.7m 120.98%
Unlock
2026
$3.4m 8.40%
Unlock
2027
$9.0m 165.68%
Unlock

Net Margin

2024 -21.71% 25.79%
2025
5.25% 124.18%
Unlock
2026
4.86% 7.43%
Unlock
2027
12.95% 166.46%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Jun '24 2025
Estimates
Earnings Per Share $ -2.86 0.60
44.03% 120.98%
P/E 2.58
EV/Sales 0.11

1 Analysts have issued a Aytu BioScience Inc forecast for earnings per share. The average Aytu BioScience Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.60
Unlock
. This is
149.18% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.60 149.18%
Unlock
, the lowest is
$0.60 149.18%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-2.86 44.03%
2025
$0.60 120.98%
Unlock
2026
$0.55 8.33%
Unlock
2027
$1.46 165.45%
Unlock

P/E ratio

Current -1.27 2,016.67%
2025
2.58 303.15%
Unlock
2026
2.82 9.30%
Unlock
2027
1.06 62.41%
Unlock

Based on analysts' sales estimates for 2025, the Aytu BioScience Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.10 54.55%
2025
0.11 8.20%
Unlock
2026
0.11 1.02%
Unlock
2027
0.11 0.46%
Unlock

P/S ratio

Current 0.13 15.69%
2025
0.14 7.28%
Unlock
2026
0.14 1.03%
Unlock
2027
0.14 0.44%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today